CAS: 40012-14-4; 6-Hydrazinyl-1,3-Dimethylpyrimidine-2,4(1H,3H)-Dione

该化合物是属于氢氮类的化学化合物,其特点是存在一个水合体功能组(R1R2C=NNNH2). 该化合物具有一个火合三酮核心,该核心由六人组成,含有氮原子和Keto组的芳香环,有助于其稳定性和再活性.两个甲基组在环的1和3个位置的存在,增强了其亲性,并可能影响其生物活动.该水合体可参与各种化学反应,使其在合成化学中成为多用途化合物.该化合物可能具有有趣的特性,例如潜在的抗微生物或抗扰动剂活动,但具体生物数据需要参考,以便详细应用.此外,其溶解性,熔点和其他物理特性将取决于所使用的溶剂和条件.

结构式图片

MSDS等安全信息

合成工艺路线路线简述

    专利信息


    专利号:US-4093812-A
    优先权日:1975-03-25
    标 题:(Nitrofuryl)pyrazoles, their synthesis and use, and compositions containing them
    发明人:RAINER GEORG
    权利人:BYK GULDEN LOMBERG CHEM FAB
    摘要:3-(5-Nitro-2-furyl)pyrazoles unsubstituted in the 5-position and 5-(5-nitro-2-furyl)pyrazoles unsubstituted in the 3-position are antimicrobials and disinfectants. The compounds are structurally represented by one of the formulae: ##STR1## wherein A is --CHO, --CN, --COOH, a protected or derived aldehyde group or a protected or derived carboxylic acid group; n B is 5-nitro-2-furyl; n R 1 is --H, substituted or unsubstituted hydrocarbyl (saturated or unsaturated; acyclic, alicyclic or aromatic; or araliphatic); substituted or unsubstituted (cycloaliphatic or aromatic) heterocyclic or acyl (carboxylic or carbonic acid); n R 2 is --H; and n n is a positive whole number of at most 2.

    专利号:US-8623880-B2
    优先权日:2009-03-23
    标 题 :Fused pyrimidine-dione derivatives as TRPA1 modulators
    发明人:CHAUDHARI SACHIN SUNDARLAL; KUMAR SUKEERTHI; THOMAS ABRAHAM; PATIL NISHA PARAG; KADAM ASHOK BHAUSAHEB; DESHMUKH VISHAL GOVINDRAO; DHONE SACHIN VASANTRAO; CHIKHALE RAJENDRA PRAKASH; KHAIRATKAR-JOSHI NEELIMA; MUKHOPADHYAY INDRANIL
    权利人:CHAUDHARI SACHIN SUNDARLAL; KUMAR SUKEERTHI; THOMAS ABRAHAM; PATIL NISHA PARAG; KADAM ASHOK BHAUSAHEB; DESHMUKH VISHAL GOVINDRAO; DHONE SACHIN VASANTRAO; CHIKHALE RAJENDRA PRAKASH; KHAIRATKAR-JOSHI NEELIMA; MUKHOPADHYAY INDRANIL; GLENMARK PHARMACEUTICALS SA
    摘要:The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

    专利号:US-9000159-B2
    优先权日:2009-03-23
    标 题 :Fused pyrimidine-dione derivatives as TRPA1 modulators
    发明人:CHAUDHARI SACHIN SUNDARLAL; KUMAR SUKEERTHI; THOMAS ABRAHAM; PATIL NISHA PARAG; KADAM ASHOK BHAUSAHEB; DESHMUKH VISHAL GOVINDRAO; DHONE SACHIN VASANTRAO; CHIKHALE RAJENDRA PRAKASH; KHAIRATKAR-JOSHI NEELIMA; MUKHOPADHYAY INDRANIL
    权利人:GLENMARK PHARMACEUTICALS SA; GLENMARK PHARMACEUTICALS SA
    摘要:The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Pharmaceutical Chemistry Journal, 18(322), 1984
    摘要:Russian Pharmacology and Toxicology, 47(146), 1984
    摘要:Kantlehner, W., Science of Synthesis, (2006) 24, 649.
    摘要:Keller, P. A.; Morgan, J., Science of Synthesis, (2006) 24, 744.
    摘要:Keller, P. A.; Morgan, J., Science of Synthesis, (2006) 24, 743.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知